Different neuromodulators rarely act independent from each other to modify neural processes but 28 are instead co-released, gated, or modulated. To understand this interdependence of 29 neuromodulators and their collective influence on local circuits during different brain states, it is 30 necessary to reliably extract local concentrations of multiple neuromodulators in vivo. Here we 31 describe results using solid phase microextraction (SPME), a method providing sensitive, multi-32 neuromodulator measurements. SPME is a sampling method that is coupled with mass 33 spectrometry to quantify collected analytes. Reliable measurements of glutamate, dopamine, 34 acetylcholine and choline were made simultaneously within frontal cortex and striatum of two 35 macaque monkeys (Macaca mulatta) during goal-directed behavior. We find glutamate 36 concentrations several orders of magnitude higher than acetylcholine and dopamine in all brain 37 regions. Dopamine was reliably detected in the striatum at tenfold higher concentrations than 38 acetylcholine. Acetylcholine and choline concentrations were detected with high consistency 39 across brain areas, within monkeys and between monkeys. These findings illustrate that SPME 40 microprobes provide a versatile novel tool to characterize multiple neuromodulators across 41 different brain areas in vivo to understand the interdependence and co-variation of 42 neuromodulators during goal directed behavior. Such data will be important to better distinguish 43 between different behavioral states and characterize dysfunctional brain states that may be evident 44 in psychiatric disorders. 45 46 New and Noteworthy 47
Abstract 26
27 Different neuromodulators rarely act independent from each other to modify neural processes but 28 are instead co-released, gated, or modulated. To understand this interdependence of 29 neuromodulators and their collective influence on local circuits during different brain states, it is 30 necessary to reliably extract local concentrations of multiple neuromodulators in vivo. Here we 31 describe results using solid phase microextraction (SPME), a method providing sensitive, multi-32 neuromodulator measurements. SPME is a sampling method that is coupled with mass 33 spectrometry to quantify collected analytes. Reliable measurements of glutamate, dopamine, 34 acetylcholine and choline were made simultaneously within frontal cortex and striatum of two 35 macaque monkeys (Macaca mulatta) during goal-directed behavior. We find glutamate 36 concentrations several orders of magnitude higher than acetylcholine and dopamine in all brain 37 regions. Dopamine was reliably detected in the striatum at tenfold higher concentrations than 38 acetylcholine. Acetylcholine and choline concentrations were detected with high consistency 39 across brain areas, within monkeys and between monkeys. These findings illustrate that SPME 40 microprobes provide a versatile novel tool to characterize multiple neuromodulators across 41 different brain areas in vivo to understand the interdependence and co-variation of 42 neuromodulators during goal directed behavior. Such data will be important to better distinguish 43 between different behavioral states and characterize dysfunctional brain states that may be evident 44 in psychiatric disorders. Despite the accumulating evidence for the interdependence of neuromodulator actions, few 73 methods exist for their simultaneous measurement in vivo and across multiple brain areas (Table  74 S1; https://github.com/att-circ-contrl/SPME_paper_SI.git). Most of these existing neurochemical 75 sensing methods allowing multi-neuromodulator sampling have a barrier to entry by requiring 76 disrupts the tissue during its initial placement of the probe or a guiding cannula resulting in 93 damage-induced release of neuromodulators that can last several hours before stable measurements 94 become possible. Moreover, MD has low affinity for hydrophobic compounds and comparatively 95 broad spatial and temporal resolution that is in the range of 200-400 µm in diameter and 10-20 96 minutes, respectively. These values are dependent on the surface area of the permeable membrane, 97 the exact method of MD, flow rate, resolution of detection methods for analytes of interest, tissue 98 tortuosity and more (Anderzhanova and Wotjak 2013; Kennedy 2013; Watson et al. 2006) . 99
Here, we set out to address some of these limitations with a novel protocol for measuring 100 multiple neuromodulators in vivo in discrete 20 minute intervals using probes optimized for solid 101 phase microextraction (SPME) (Pawliszyn 2000 (Pawliszyn , 2012 . SPME probes are thin (200 µm) wires of 102 arbitrary length coated with an inert porous polymeric matrix using biocompatible binder on one 103 end where molecules with appropriate size and affinity migrate via passive diffusion and are 104 retained by weak intermolecular interactions (see Methods). SPME provides an alternate method 105 for data collection which can then be analyzed by tools such as mass spectrometers. This method 106 has been shown to extract in neural tissue dynamic changes in dopamine (DA) and serotonin (5-107 HT) levels with comparable precision to MD (Cudjoe et al. 2013; Cudjoe and Pawliszyn 2014). 108
Additionally, due to the similarity of SPME probes to commonly used microelectrodes in 109 electrophysiological recordings, relatively minor adjustments will allow for the adaptation of 110 conventional microelectrode driving systems for SPME use. This, combined with post collection 111 analysis through standard chemistry facilities makes SPME an attractive and easy-to-use tool for 112 electrophysiology labs. 113 SPME has the potential to be a powerful new tool to compliment the mentioned methods 114 well suited for neurochemical profiling that spans both multiple neuromodulators as well as 115 multiple brain regions simultaneously. Such data will allow for global observation of slow 116 neuromodulator dynamics that could better inform our hypotheses and help relate global 117 neuromodulator levels to electrophysiology and behavior. 118
Thus, the ability of SPME to report major neuromodulators as well as glutamate and GABA 119 were tested in two behaving rhesus macaques. Probes were repeatedly and simultaneously inserted 120 into two cortical regions and the striatum to observe inter-areal differences between extracellular 121 neuromodulator concentrations. We found that extracellular concentrations of glutamate, 122 dopamine, acetylcholine and choline could be reliably distinguished and differed systematically 123 between brain regions. 124
Methods 125
reward volumes on all recording days. In both tasks, stimulus presentation and reward delivery 140 was controlled through MonkeyLogic (http://www.brown.edu/Research/monkeylogic/). 141 142 SPME protocol and Fabrication of SPME Probes 143
We provide a visual overview of the complete SPME protocol used here in Fig S2  144 (https://github.com/att-circ-contrl/SPME_paper_SI.git) and delineate the chemical materials, LC-145 MS/MS analysis, and detailed quantitation of neuromodulators in the Supplementary Materials 146 (https://github.com/att-circ-contrl/SPME_paper_SI.git) and in a companion paper (Lendor et al. 147 2019) . All measurements used miniaturized SPME probes that were manufactured by repeated 148 dip-coating of stainless steel wires in a suspension of extracting phase in a binder. This general 149 procedure reported previously (Gómez-Ríos et al. 2017), has been modified to fit the purpose of 150 in vivo brain sampling (Lendor et al. 2019) . The 3 mm long tip of the wire was acid-etched down 151 to approx. 100 µm to create a recession capable of accommodating thicker layer of coating without 152 significantly increasing the total probe diameter. The extracting phase was an in-house synthesized 153 hydrophilic-lipophilic balance polymer functionalized with benzenesulfonic acid to introduce 154 strong cation exchange properties (HLB-SCX). The monodispersed polymeric particles with 155 diameter of approx. 1 µm were suspended in the binder consisting of 7% polyacrylonitrile 156 dissolved in N,N-dimethylformide (w/v), ensuring the particles-to-binder ratio at 15% (w/v). The 157 extracting phase suspension was prepared one day before the probe coating, homogenized by 158 sonication and stirred at 800 rpm overnight. Several layers of coating were deposited on the 159 modified wires, resulting in total coating thickness of ≈50 µm and total probe diameter of 195 µm. 160
The average pore size of the extracting phase was measured at 1.2nm. Before the use, the probes 161 were cleaned with the mixture of methanol, acetonitrile and 2-propanol (50:25:25, v/v/v), activated 162 in the mixture of methanol and water (50:50. v/v) and sterilized in steam for 15 min at 121°C. 163
During the sampling, SPME probes were inserted into sheathing cannulas to protect the coating 164 and prevent it from extracting compounds on the way to the target brain area. The cannulas 165 underwent the same cleaning and sterilization procedure as the probes and then the lengths of both 166 components of the SPME assembly were adjusted to 60-70 and 70-80 mm for the probes and 167 cannulas, respectively. 168
169

MRI Guided Electrophysiological Mapping of Target Tissue 170
The anatomical coordinates of the brain regions of interest were first identified through 3 T MR 171 images. The MR images were then verified with extracellular electrophysiological recordings of 172 the target areas, which provided the gray and white matter boundaries for the cortical sites and the 173 dorsal most aspect of the head of the caudate nucleus. Tungsten microelectrodes were 200 µm 174 thick with an impedance of 1-2 MW. All electrodes, SPME probes and their accompanying guiding 175 cannulas were driven down into the brain and later out using software-controlled precision 176 microdrives (Neuronitek, ON, Canada). Electrodes were connected to a multichannel acquisition 177 processor (Neuralynx Digital Lynx system, Inc., Bozeman, Montana, USA) which was used for 178 data amplification, filtering and acquisition of spiking activity. Spiking activity was obtained by 179 applying a 600-8000 Hz bandpass filter, with further amplification and digitization at a 32 KHz 180 sampling rate. For every recording day, electrodes were lowered until the first detection of spiking 181 activity (indicative of gray matter) at the depth suggested by the MR images. 182
183
SPME Sampling and Post-Processing Procedures 184
All three SPME assemblies (example of sampling using one assembly in Fig 1A-C) were 185 simultaneously driven to 200 µm above the point of first spiking detection. SPME assemblies were 186 located ~1 mm away from the electrode penetration location. Then, only the SPME probes were 187 about the time it takes until equilibrium is reached in a concentration independent manner that is 202 helpful in estimating a lower limit for extraction times to collect quantifiable analyte 203 concentrations. After the 20 min extraction event, all SPME probes were driven back 3 mm into 204 the guiding cannulas and all SPME assemblies were withdrawn from the brain (Fig 1A-C) . The 205 microdrives were then removed from the chamber to enable unclamping of the SPME probes, a 206 brief wash and then storage in glass vials surrounded by dry ice until placing them into a -80°C 207 freezer. One entire sampling event (one extraction in 3 different brain areas together with 208 assembling the SPME probes and cannulas, driving into and out of brain, washing and preparing 209 for storage) was performed within 50 min, except for the first sampling event in each sampling 210 day. The first sampling event, with the area identification using electrophysiology recording, was 211 performed within 75 min. The removal of the SPME microprobe from the gray matter and the 212 positioning of a new SPME microprobe in the same location limits the temporal continuity of 213 sampling. We believe that further optimizing of the SPME microprobe switching procedure with 214 e.g. pre-loaded SPME probes will allow replacing SPME fibres within 2-10 min. Alternatively, 215 SPME microprobes could be used in spatially separate but adjacent guiding tubes (separation of 216 ~300µm), which would allow to switch sampling from one to other probe without temporal delays. 217 218
Neuromodulator detection and quantitation 219
Detection and quantitation of neuromodulators followed previously established procedures 220 Monkey As had an additional 3 days of recording with one sample collected on each day. Overall 241 we collected and analyzed 12 probes in monkey As and 9 probes in monkey Ke. We were 242 specifically interested in major neuromodulators and neurotransmitters but successfully measured 243 other compounds such as amino acids (e.g. glutamine, taurine, phenylalanine etc) that we do not 244 discuss here. 245
To allow comparison of the SPME extraction results to those typically reported in 246 microdialysis studies, we calculated the relative change in measured concentrations across the 247 three successive sampling events per session pooled across monkeys to enhance the statistical 248 power of the analysis (Fig 2) . Relative to the end of the first sampling event, the second and third 249 sampling events started after 40 minutes and 100 minutes respectively. We expected that the 250 variability of measurements (indexed as standard error of the median) is comparable to repeatedly 251 measured microdialysis of an identical, active brain state. We found that measured concentrations 252 did not change significantly across sampling events for any compound area combination 253 (Wilcoxon rank sum test; Fig 2) . 254 We found that four target neurotransmitters and neuromodulators were reliably detected in 255 each animal: glutamate, dopamine, acetylcholine, and choline. Serotonin was also detected on 256 several probes but always near the limit of detection (LOD) and therefore was excluded from 257 analyses here (Lendor et al. 2019 ). Glutamate concentrations were several orders of magnitude 258 higher than all other observed compounds of interest in all areas and both animals. Relative to 259 glutamate, choline concentrations were >15 times lower, DA concentrations were >700 lower and 260
ACh concentrations were >8300 times lower (Fig 3) . 261
Glutamate concentrations (across areas), measured as median ± standard error, ranged from 262 159,147 (±19,395) to 233,659 ng/mL (±33,917) in monkey As, and from 135,523 (±22,945) to 263 184,333 ng/mL (±33,516) in monkey Ke. In both monkeys, glutamate concentrations were highest 264 in the head of the caudate, which was significantly different from glutamate concentrations in the 265 premotor cortex in monkey As (kruskal-wallis test with Tukey's HSD correction, p = 0.048) but 266 not in monkey Ke (kruskal-wallis test with Tukey's HSD correction, p = 0.847, n.s.). Glutamate 267 concentrations between the caudate and PFC, as well as the PFC and premotor cortex were not 268 significantly different for either animal. Comparisons between monkeys showed no significant 269 differences between the glutamate concentrations in any of the measured areas (Fig 3) . 270
In addition to glutamate, dopamine could be reliably detected in both monkeys in the 271 caudate at concentrations of 232 ng/mL (±47) in monkey As, and 226 ng/mL (±31) in monkey Ke. 272
These concentrations were similar between monkeys (Wilcoxon rank sum test p = 1, n.s.). 273
Dopamine was not found above detection limits in frontal cortex. 274
Acetylcholine measurements in the three brain areas ranged from (across areas) 25 (±2) to 275 36 ng/mL (±5) in monkey As, and from 29 (±2) to 36 ng/mL (±4) in monkey Ke. In monkey As, 276 extracellular ACh concentrations between the caudate and premotor cortex were significantly 277 different (kruskal-wallis test with Tukey's HSD correction, p = 0.008). Cortical areas were not 278 significantly different from one another (kruskal-wallis test with Tukey's HSD correction, p = 279 0.476, n.s.) nor was there a significant difference between the caudate and PFC (kruskal-wallis test 280 with Tukey's HSD correction, p = 0.145, n.s.). In monkey Ke, only one cortical region had 281 concentrations of ACh above detection limits, which approached significant difference to the 282 concentrations measured in the caudate (Wilcoxon rank sum test, p = 0.08). Measurements of 283 extracted ACh in the pre-motor cortex of monkey Ke were consistently below detection limits ( Fig  284   3) . 285 We also measured choline which is a main product of the enzymatic breakdown of the 286 highly regulated ACh and which is a main indicator of attentional modulation of cholinergic 287 activity in frontal cortex (Parikh et al. 2007 ). Choline concentrations ranged across areas from 288 2,914 (±590) to 5,078 ng/mL (±675) in monkey As, and 3,408 (±3,705) to 5,533 ng/mL (±860) in 289 monkey Ke. Choline concentrations between the caudate and premotor cortex were significantly 290 different in monkey As (kruskal-wallis test with Tukey's HSD correction, p = 0.030), but not in 291 monkey Ke (kruskal-wallis test with Tukey's HSD correction, p = 0.729, n.s.). All other area 292 comparisons were not significant for both monkeys. Comparisons of choline concentrations 293 between monkeys were not significant in any of the measured areas. 294
Overall, serotonin concentrations were not observed as reliably as the other reported 295 neurochemicals and therefore were excluded from the main analyses. However, in monkey As, 296 serotonin was observed near the LOD in the prefrontal cortex as well as the caudate in a subset of 297 probes. Within the 9 probes placed in both areas, serotonin was detected in 22% of samples (2/9 298 probes) in the prefrontal cortex and 33% of samples (3/9 probes) in the caudate nucleus. Serotonin 299 observations ranged from 149 ng/mL to 232 ng/mL with a median of 171 ng/mL (±18.5 ng/mL; 300 standard error of the median) with a LOD of 100 ng/mL. The proximity of the measurements to 301 the LOD suggest that the other probes likely collected concentrations of serotonin below the 302 We demonstrated the reliable measurements of glutamate, dopamine, acetylcholine and choline 306 simultaneously within cortical and subcortical regions of awake and behaving macaques using 307 coated microprobes optimized for solid phase microextraction. Glutamate concentrations were 308 several orders of magnitude higher than dopamine, acetylcholine and choline across brain regions. 309
Extracellular concentrations of choline, dopamine and acetylcholine were detected at >15, >700, 310 and >8,300 times lower than glutamate respectively. Dopamine was readily detected in the caudate 311 but not observed at detectable concentrations in the cortical regions measured. Acetylcholine 312 concentrations showed a statistical trend of being different between the caudate and measured 313 cortical areas and with high consistency between monkeys. Choline concentrations, a product of 314 acetylcholine degradation as well as a precursor for its synthesis, were negatively correlated with 315 acetylcholine (R = -0.355; p = 0.01). Together, these findings provide new and rare insights about 316 the neurochemical circuit profiles during an active brain state in three areas of the primate fronto-317 striatal network. 318
The high consistency of measured concentrations within animals, between brain areas and 319 between monkeys suggests that SPME microprobes could provide a versatile neuro-technique for 320 Our results suggest that SPME probes provide reliable and sensitive measurements in consecutive 382 sampling events within an experimental session and between sessions on consecutive days. These 383 results were obtained while we controlled brain states across measurement events by engaging 384 animals in a cognitive task. This experimental control could have contributed to the comparable 385 extracellular levels of neuromodulators from sample to sample within and between days from 386 similar brain locations (Fig 2) neurochemicals with SPME is extremely high and outperforms many reported microdialysis 397 studies. We present 100% reliability in reporting glutamate and choline concentrations in all brain 398 regions and subjects. Acetylcholine concentrations were reported with 100% reliability in one 399 animal and 92% (11/12 probes) in the other within the prefrontal cortex, 0% reliability (below 400 detection threshold) in one animal and 83% (10/12 probes) in the other within the premotor cortex 401 and 100% reliability in one animal and 92% (11/12 probes) in the other within the caudate. 402
Dopamine concentrations were reported with 100% reliability in both animals in the caudate and 403 were not observed above detection thresholds in the cortex. 404
405
Qualities and Advantages of SPME. Our results illustrate several inherent advantages of using 406 SPME to measure neurochemical profiles in brain circuits (Lendor et al. 2019) . As illustrated in 407 where the SPME coating is placed allows for robust placement within the brain. The narrow 410 diameter of the SPME probe that is within the range common to electrodes for electrophysiological 411 recordings, allows for repeated, simultaneous sampling at multiple sites without observable 412 changes to detected extracellular neuromodulator levels using 20-minute sampling times. 413 Spatial Resolution. In principle, the spatial resolution of the SPME measurements are 414 capable of reflecting laminar concentration gradients across areas as small as several tens of 415 micrometers. In our protocol we coated 3mm in length with 50 µm of thickness and desorbed the 416 entire area into an organic solvent mixture for subsequent LC-MS/MS analysis. However, with the 417 use of other techniques, such as desorption electrospray ionization (DESI), which represents a 418 direct-to-MS approach (Deng et al. 2014), much smaller areas of the SPME matrix may be 419 analyzed at a time allowing for laminar or near-laminar resolution. Direct coupling of SPME fibres 420 to MS is the preferred mode, as it provides the most rapid analysis thus preventing diffusion of 421 compounds within the coating and smearing the imprinted layer information. If diffusion of 422 molecules within the fibre is high, it can be prevented by, for example, the inclusion of a divider 423 between two halves of the coating. This would allow the simultaneous measurement of separated 424 compartments of a cortical column. The absolute spatial resolution of SPME is difficult to estimate 425 as SPME operates through diffusion and dynamic equilibration similar to MD. As a consequence, 426 the sampled volume will depend on sampling time, the compound's diffusion coefficient, as well 427 as the target tissue and its properties affecting the rate of diffusion such as tortuosity (Syková 428 2004) . 429
Temporal Resolution. Several factors determine the appropriate extraction time using 430 SPME. Depending on the goals of an experimenter, resolutions below 5 minutes may be achieved 431 as the detection limit is reached within the first few minutes for most compounds tested (Fig 1D-432   E) . As sampling continues, the SPME coating will eventually reach an equilibrium point with the 433 external environment (Fig 1D-E) . In principle, sampling times beyond a stable equilibrium point 434 will result in the same extracted values of compounds. However, in the brain there is no single 435 stable equilibrium point and thus, even with long sampling times, there will be some variation in 436 extracted concentrations. Within the dynamic regime, we can still calculate environmental 437 concentrations from which sampling occurred given knowledge of the extraction time and the 438 dynamic range. The lower limit of this dynamic range that can be informative is determined by the 439 coating's physicochemical characteristics and sample's properties and in practice also volume of 440 desorption and sensitivity of the MS. The analytical technique's sensitivity also practically 441 determines the thickness of the SPME coating as thinner coatings could in principle increase 442 temporal resolution but would extract less compounds overall requiring higher sensitivity to detect. 443
With higher sensitivity, less time is required for the thin coating to extract sufficient amounts to 444 exceed limits of detection and quantitation. This then means that the compound with regards to 445 which the sensitivity is the lowest, limits the temporal resolution because it will have the slowest-446 to-reach detectable concentration. But as long as the detection threshold is exceeded, the extraction 447 time profiles allow for the calculation of the equilibrium concentration even with pre-equilibrium 448 sampling. However, making measurements in the dynamic range requires consistency of extraction 449 times as differences in time will lead to variations of extraction yields in a range that can be 450 estimated from the SPME extraction time profiles (Fig 1D-E) . Given the dynamic nature of brain 451 networks and the lack of a stable equilibrium point, we expect consistency in brain states to be one 452 of the biggest factors in reducing replicated variability. Moreover, SPME measurements are 453 inherently an average of the temporal dynamics of the target tissue milieu. This means that due to 454 the bi-directional exchange of neuromodulators from the extracellular space and the SPME 455 coating, longer periods of stable concentration gradients will be more strongly reflected in the 456 extracted measurements. 457
Utility and Ease of Use. SPME based microprobe extraction allows for multiple 458 simultaneous measurements that can be reliably repeated within the same measurement sessions 459 at the same locations with no evidence of damage induced disruption of the neurochemical 460 environment. Another critical advantage of SPME over comparable MS-analysis based methods 461 such as MD is its ease of use and accessibility. Due to their similar size to recording 462 microelectrodes used for electrophysiology, little adjustment is required for conducting SPME 463 measurements using existing acute microelectrode positioning systems. Measurements in deeper 464 structures should use an accompanying guide tube (Fig 1C) as travelling through non-target tissue 465 will result in unwanted chemical collection. Beyond the collection, a chemistry core could apply 466
LC-MS/MS to the probes allowing for relatively easy quantitation of extracellular compounds of 467 interest. 468
Detection Methods. SPME is ultimately a sampling method, much like MD, that provides 469 data for analytical tools such as chromatography and mass spectrometry. In fact, once SPME 470 analytes have been desorbed from the probe into a solvent, data provided by SPME and MD are 471 treated very much the same. Thus, the advancement in detection limits and reliability of post-hoc 472 analytical methods utilized by MD also benefit SPME, and vice versa. However, SPME sample 473 analysis is more reliably and conveniently coupled to LC-MS/MS as it lacks issues such as high 474 salt content of collected dialysate that MD suffers from (Guihen and Connor 2009) . 475
Extension of SPME measurements beyond classical neuromodulators. A unique advantage 476
of SPME over alternative methods of in vivo detection of compounds within the brain is its 477 potential affinity for hydrophobic compounds. Although MD is capable of collecting 478 phenylalanine, etc) that we reliably detected but do not discuss here. In practice, the detection of 487 very polar molecules such as monoamines and catecholamines requires coating chemistry that 488 facilitates hydrophilic compound extraction. Comparatively many lipids play important roles in 489 intracellular signaling and have been suggested to provide biomarkers for psychiatric disorders 490 (Tamiji and Crawford 2011; Yehuda et al. 1999) , therefore making SPME a potentially versatile 491 and comprehensive tool for brain neurochemistry studies. 492 493 Future direction and improvements to the SPME neurochemical sensing. The next immediate 494 steps for the continued testing of SPME's utility as a neurochemical sampling method is to evaluate 495 its ability to report behavioral state dependent changes in extracellular neuromodulator 496 concentrations. Similar testing as described here will be conducted with varying, stable behavioral 497 states such as passive engagement, active task engagement, and drowsy/sleepiness. We predict 498
that the various brain regions tested will display different changes in neuromodulator 499 concentrations as a function of behavioral state. 500
Several improvements to the protocol can be made in order to make SPME more 501 informative. Using a more sensitive MS would reduce detection thresholds and increase sensitivity 502 in detecting compounds not successfully measured here such as GABA, serotonin or 503 norepinephrine. This would be very impactful, especially in the case of serotonin for reasons 504 discussed above. Additionally, efforts could be made to improve the extracting phase synthesis 505 and functionalization protocols and increase the extracting capabilities of SPME probes. 506
Moreover, in order to decrease the MS background and interferences in the range of small 507 molecules, derivatization strategy could be considered. 508
For GABA, the most promising strategy is post-desorption derivatization by reagent 509 increasing the compound's hydrophobicity resulting in better MS signal such as benzoyl chloride 510 (Wong 2016). Catecholamine and acetylcholine detection may be improved by optimizing the 511 post-sampling analysis pipeline. Improvements can be made at several steps in order to better 512 preserve and quantify catecholamines: (1) faster coupling of sampling to desorption (2) trying 513 various antioxidant solutions and other preservatives for maintaining catecholamine integrity and 514
(3) faster analysis of the desorbed analytes. Faster coupling of sampling to desorption could be 515 achieved through a more stream-lined process of fibre placement and retraction involving a static 516 cannula maintained through several sampling events. This mechanism would also allow for a faster 517 replacement of SPME probes resulting in a shorter delay between consecutive measurements. 518 A preliminary experiment using both spiked artificial cerebra-spinal fluid (aCSF) and lamb 519 brain homogenate with very high, known concentrations of all target compounds yielded 520 detectable concentrations of all target compounds indicating that the extracting phase of the SPME 521 probe is capable of capturing all compounds of interest. Furthermore, simultaneously collected 522 replicates displayed very little loss of collected compounds over several days within a -80°C 523 freezer (data not shown). Various strategies were compared for storage and placement of extraction 524 fibres in desorption solvent prior to -80°C storage seemed most reliable for many compounds and 525 will be the storage method utilized in the future. Such findings neither support nor antagonize the 526 suggested strategies for improving SPME yield and sensitivity in primates as detection properties 527 within the aCSF and lamb brain homogenate may not accurately reflect those observed in vivo in 528 primates. This is likely contributed to by the dynamic and highly regulated nature of target 529 compounds within the extracellular space of the brain and the dynamic equilibrium between the 530 extracting phase of the SPME probes and the extracellular environment. Further tests of the 531 possible differences between these mediums and improvement strategies to SPME probes are 532 subject for future studies. . Multi-modulator measurements, as 558 described here, will allow for a better understanding of pharmacological agents, as well as provide 559 novel insights into the development of more effective drugs or combinations of drugs to better 560 treat the clinical population. 561 562 Conclusion. We described a novel SPME protocol capable of simultaneous, multi-modulator 563 measurements of multiple brain regions. Our results suggest that SPME both supplements current 564 methods of neuromodulator detection and allows for novel measurements previously not possible 565 for the investigation and dissection of neuromodulatory systems, their role in physiological brain 566 processes and their modulation by pharmacological agents. Ministry of Economic Development and Innovation (MEDI). We thank Dr. Hongying Wang for 572 invaluable help with animal care. We thank Thermo Scientifc for providing the triple quadrupole 573 mass spectrometer TSQ Quantiva used in this work as a loan to our laboratory. The authors 574 thankfully acknowledge Pfizer Canada Inc., Merck Canada Inc., Quebec Consortium for Drug 575 Discovery (CQDM), Brain Canada, and Ontario Brain Institute for the grant "Solid phase 576 microextraction-based integrated platform for untargeted and targeted in vivo brain studies". 577 578
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None of the authors have any conflict to disclose. 580 (A) Dimensions of the SPME probe and the accompanying cannula. There was a 3000 µm buffer 799 from the opening of the cannula and the start of the SPME coating. The SPME coating spanned 800 195 µm at the tip. The SPME coating made up the terminal 3000 µm of the entire probe and was 801 placed in a cannula with an internal diameter of 200 µm and an external diameter of 270 µm. (B)  802 Tungsten microelectrodes were lowered into the brain guided by 3 T magnetic resonance (MR) 803
images in order to map the depth at which detectable spiking was observed matching expectations 804 from the MR images. (C) SPME probes and their accompanying cannulas in all brain areas were 805 then simultaneously lowered to 200 µm above the point of first observable firing in the target brain 806 region and the SPME probes were lowered to expose only the 3000 µm SPME coating. After 20 807 minutes of extraction, the SPME probes were then retracted 3000 µm back into the cannula and 808 the probes plus their accompanying cannulas were removed from the brain. The table inset into  809 the figure provides the velocities and times of each probe and cannula as they transitioned between 810 the extraction steps. one sampling event to the start of the next sampling event was 40 minutes (STD 2 minutes) making 826 the second sampling event 40 minutes and the third 100 minutes from the initial measurement. No 827 significant change was observed for any neuromodulator in any brain region (Wilcoxon rank sum 828 test). Note that a single prefrontal choline data point was excluded in this analysis for being >4 829 standard deviations from the median (data point is present in Fig 3a) . 
LC-MS/MS Analysis
On the day of analysis, the SPME probes were defrosted and desorbed into 40 µL of linear return to initial conditions and re-equilibration for 1 min, yielding total time of 6.5 min. The injection volume was 10 µL. MS/MS analysis was performed with electrospray ionization in positive mode under selected reaction monitoring conditions, with two MS/MS transitions for each neuromodulator (quantifier and qualifier) and one for each IS.
Quantitation of neuromodulators
Individual stock standard solutions of all targeted neuromodulators were prepared in methanol or water with 0.1% formic acid at a concentration of 1 mg/mL and stored at −80 °C for maximum of one month. In order to calculate the amounts of neuromodulators extracted by each probe, In order to calculate the concentrations of neuromodulators in brain, matrix-matched external calibration approach was used. The surrogate matrix consisted of 2% agar gel mixed with brain homogenate in the ratio 1:1 (v/w). The homogenized brain tissue was earlier incubated with 1 mM PMSF for 1 h at 37°C to prevent enzymatic digestion of acetylcholine in the calibrator samples. Due to several target compounds being present in brain homogenate at high concentrations (e.g. for glutamate and choline the "blank" brain homogenate matrix doesn't exist), their quantitation was based on signals of their deuterated isotopologues. The calibrator samples were prepared in the surrogate matrix with concentrations of neuromodulators ranging from 5 to 3000 µg/mL for the isotopically labelled compounds or from 10 to 2000 ng/mL for the remaining compounds.
The extractions were carried out with SPME probes manufactured and pre-treated identically to the probes used for in vivo sampling and using the same 20 min extraction time and desorption conditions as for the real samples. The amounts of neuromodulators extracted from the calibrator samples were determined in the same way as described above and plotted against concentrations of calibrators. The resulting weighted linear regression equations were applied to the amounts of neuromodulators extracted from the in vivo samples, yielding values of concentrations of the compounds of interest in brain.
The limits of detection (LOD) were estimated as the levels corresponding to the signal to noise ratio of 3 and were calculated based on the signal of blank calibrator sample (considered as the noise). Fig S1. Behavioral task that the monkeys were engaged in. Briefly, the monkey was expected to fixate a central fixation point until criterion when two graded stimuli appeared. The graded stimuli acquired color and motion, of the graded stripes, features in either order. The two stimuli then either simultaneously dimmed (go-signal), or dimmed one at a time in either order. The monkey, through trial and error, identified the rewarded stimulus via its color feature which was the sole identifying feature informative of reward. The monkey was then expected to wait until the dimming of the selected stimulus and respond in the same direction as the motion of the graded stripes on the chosen stimulus. If the monkey correctly accomplished this, it would receive deterministic reward in the form of liquid juice. Monkey As was engaged in a variation of this task with reduced complexity in order to match monkey Ke in performance and reward acquisition over the sampling period. Figure reproduced 
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